Syndax Pharmaceuticals Inc
SNDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395937
In the last 90 days, Syndax Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 242 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Syndax Pharmaceuticals Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 136
- +4 vs. Q4 2021
- Shares held
- 54.6M
- +2.14M (+4.1%) vs. Q4 2021
- Total value
- $948.4M
- −$198.6M (−17.3%) vs. Q4 2021
- New holders
- 27
- 53 more added
- Sold out
- 23
- 31 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $2.36B |
| Q1 2026 | 247 | $2.32B |
| Q4 2025 | 230 | $2.10B |
| Q3 2025 | 227 | $1.56B |
| Q2 2025 | 217 | $952.6M |
| Q1 2025 | 219 | $1.24B |
| Q4 2024 | 216 | $1.30B |
| Q3 2024 | 210 | $1.71B |
| Q2 2024 | 196 | $1.79B |
| Q1 2024 | 189 | $2.15B |
| Q4 2023 | 177 | $1.92B |
| Q3 2023 | 175 | $1.03B |
| Q2 2023 | 166 | $1.48B |
| Q1 2023 | 163 | $1.54B |
| Q4 2022 | 160 | $1.82B |
| Q3 2022 | 139 | $1.44B |
| Q2 2022 | 121 | $1.06B |
| Q1 2022 | 136 | $948.4M |
| Q4 2021 | 132 | $1.15B |
| Q3 2021 | 123 | $938.0M |
| Q2 2021 | 115 | $861.9M |
| Q1 2021 | 130 | $1.08B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Syndax Pharmaceuticals Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 239,829 | $4.17M | 0.00% | +69,356+40.7% | Added |
| Lord, Abbett & Co. LLC | 293,349 | $5.10M | 0.01% | +5,297+1.8% | Added |
| Charles Schwab Investment Management Inc | 341,304 | $5.93M | 0.00% | +35,308+11.5% | Added |
| Point72 Asset Management, L.P. | 360,000 | $6.26M | 0.03% | +6,900+2.0% | Added |
| Two Sigma Advisers, LP | 368,352 | $6.40M | 0.02% | +13,800+3.9% | Added |
| DAFNA Capital Management LLC | 371,987 | $6.46M | 1.68% | +75,452+25.4% | Added |
| Goldman Sachs Group Inc | 408,263 | $7.09M | 0.00% | +44,602+12.3% | Added |
| Millennium Management LLC | 426,113 | $7.41M | 0.01% | +407,351+2,171.1% | Added |
| Norges Bank | 484,900 | $8.43M | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 486,228 | $8.45M | 0.00% | +32,552+7.2% | Added |
| Phoenix Holdings Ltd. | 525,856 | $9.14M | 0.16% | +183,500+53.6% | Added |
| Palo Alto Investors LP | 612,600 | $10.6M | 0.82% | +13,700+2.3% | Added |
| Morgan Stanley | 697,701 | $12.1M | 0.00% | +420,225+151.4% | Added |
| Paradigm Biocapital Advisors LP | 701,356 | $12.2M | 3.22% | +248,265+54.8% | Added |
| Sofinnova Investments, Inc. | 717,064 | $12.5M | 1.05% | −234,162−24.6% | Reduced |
| Geode Capital Management, LLC | 855,415 | $14.9M | 0.00% | +90,788+11.9% | Added |
| Dimensional Fund Advisors LP | 884,334 | $15.4M | 0.00% | +90,634+11.4% | Added |
| Aisling Capital Management LP | 1,025,000 | $17.8M | 9.61% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,078,641 | $18.7M | 0.04% | −121,359−10.1% | Reduced |
| Eventide Asset Management, LLC | 1,165,000 | $20.2M | 0.32% | 00.0% | Unchanged |
| HealthCor Management, L.P. | 1,180,500 | $20.5M | 1.42% | +22,940+2.0% | Added |
| Sphera Funds Management Ltd. | 1,277,413 | $22.2M | 3.72% | +100,828+8.6% | Added |
| 683 Capital Management, LLC | 1,581,653 | $27.5M | 1.63% | +186,161+13.3% | Added |
| Citadel Advisors LLC | 1,825,440 | $31.7M | 0.04% | −193,387−9.6% | Reduced |
| Wellington Management Group LLP | 1,833,930 | $31.9M | 0.01% | +235,164+14.7% | Added |
| Kynam Capital Management, LP | 1,932,800 | $33.6M | 10.92% | +976,635+102.1% | Added |
| PFM Health Sciences, LP | 2,043,377 | $35.5M | 1.37% | −60,135−2.9% | Reduced |
| OrbiMed Advisors LLC | 2,158,300 | $37.5M | 0.61% | +177,000+8.9% | Added |
| Avoro Capital Advisors LLC | 2,220,500 | $38.6M | 0.70% | +45,500+2.1% | Added |
| State Street Corp | 2,380,337 | $41.4M | 0.00% | −99,867−4.0% | Reduced |
| BVF Inc | 2,394,714 | $41.6M | 1.66% | +295,000+14.0% | Added |
| Vanguard Group Inc | 2,432,438 | $42.3M | 0.00% | +95,068+4.1% | Added |
| Nantahala Capital Management, LLC | 2,692,303 | $46.8M | 3.24% | −158,256−5.6% | Reduced |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55.5M | 4.73% | +3,195,403 | New |
| BlackRock Inc. | 3,798,150 | $66.0M | 0.00% | +108,256+2.9% | Added |
| Avidity Partners Management LP | 4,823,400 | $83.8M | 1.86% | 00.0% | Unchanged |
| Frazier Management LLC | 0 | $0 | 0.00% | −2,772,062−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −310,377−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −283,954−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −175,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −123,303−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −111,382−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −46,226−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −41,931−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −38,347−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −34,997−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −26,376−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −23,529−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,778−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,300−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −9,860−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −5,147−100.0% | Sold out |
| Cross Creek Advisors, LLC | 0 | $0 | 0.00% | −2,649−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −377−100.0% | Sold out |
| Cypress Capital Management LLC (WY) | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |